Skip to main content
Retour
Watch Compare

ACRO BIOMEDICAL CO., LTD.

Qualité des données : 100%
ACBM
OTC Services Amusement & Recreation
0,03 €
0,00 € (0,00%)
Cap. Boursière: 1,56 M
Prix
0,03 €
Cap. Boursière
1,56 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -196 302,0

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio0,01
Interest CoverageN/A

Valorisation

PE (TTM)
-15,43
En dessous de la moyenne du secteur (-1,17)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Services (502 pairs)
Métrique Action Médiane du Secteur
P/E -15,4 -1,2
P/B — 1,4
ROE % — -16,0
Net Margin % — -18,3
Rev Growth 5Y % — 4,2
D/E — 0,4

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -101 146,0
ROE N/A ROA -351,20%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -196 302,0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,01
Interest Coverage N/A Asset Turnover 0,00
Working Capital -432 619 Tangible Book Value -432 619
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -15,43 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -12,57%
Market Cap 1,56 M Enterprise Value 1,56 M
Per Share
EPS (Diluted TTM) 0,00 Revenue / Share 0,00
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 194,08%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0,0 0,0 0,0 658 500,0 —
Net Income -101 146,0 -42 297,0 -8,81 M -15,87 M -7,70 M
EPS (Diluted) 0,00 0,00 -0,15 — —
Gross Profit — — 0,0 140 500,0 259 500,0
Operating Income -154 024,0 -37 958,0 -8,80 M -15,87 M -7,69 M
EBITDA — — — — —
R&D Expenses — 0,0 4,79 M 10,08 M —
SG&A Expenses 154 024,0 37 958,0 3,52 M 5,93 M 2,67 M
D&A — — — — —
Interest Expense — — 3 206,0 358,0 893,0
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 14 098,0 31 974,0 58 459,0 687 486,0 761 077,0
Total Liabilities — 326 946,0 315 473,0 201 116,0 117 370,0
Shareholders' Equity -386 964,0 -294 972,0 -257 014,0 486 370,0 643 707,0
Total Debt — — — — —
Cash & Equivalents — — — — —
Current Assets 14 098,0 5 076,0 1 626,0 657 537,0 706 415,0
Current Liabilities 401 062,0 326 946,0 288 575,0 201 116,0 91 651,0